Rapid response of nail psoriasis to secukinumab in patients with moderate to severe psoriasis after 12 weeks of treatment with a total of 24 weeks of follow‐up
Gang Min Go, Yong Jun Hong, Hyun Ji Lee, Miri Kim
IF 1.8Australasian Journal of Dermatology
초록
Secukinumab rapidly improved nail psoriasis after 12 weeks of treatment, with further enhancement at 24 weeks, suggesting its potential as a potent therapeutic option for nail psoriasis.
키워드
SecukinumabMedicinePsoriasisDermatologyNail (fastener)Psoriasis Area and Severity IndexClinical endpointDermatology Life Quality IndexPlaque psoriasisPsoriatic arthritis